
Laricef 1gm/1gm Injection
Marketer
Larion Life Sciences Pvt Ltd
Salt Composition
Cefoperazone (1gm) + Sulbactam (1gm)
Overview Laricef 1gm/1gm Injection
Cefixime and Sulbactam 1g/1g injection is a dual-action antibiotic. It's used to combat diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. This injectable medication must be administered only by a qualified healthcare provider. Consistent adherence to the prescribed dosage schedule is crucial; completing the entire course of treatment is vital, even with symptom improvement. Premature cessation may compromise the medication's effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical consultation. Seek immediate medical attention for allergic reactions such as rash, pruritus, edema, or dyspnea. Inform your physician of all current medications, including over-the-counter drugs, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Uses of Laricef 1gm/1gm Injection
Managing bacterial infections
Major Benefits of Laricef 1gm/1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Laricef 1gm/1gm Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Laricef 1gm/1gm Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Laricef 1gm/1gm Injection works:
Laricef, a 1g Cefoperazone and 1g Sulbactam injectable solution, combines an antibiotic with a beta-lactamase inhibitor. Cefoperazone's antibacterial action disrupts bacterial cell wall synthesis, hindering their ability to survive. Sulbactam counters bacterial resistance mechanisms, bolstering Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol alongside Laricef 1gm/1gm Injection can lead to adverse effects including facial redness, rapid pulse, queasiness, dehydration, pectoral discomfort, and hypotension (a Disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
Pregnancy use of Laricef 1gm/1gm Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Laricef (1g/1g) poses no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, and consequently, no apparent infant harm.
DrivingCONSULT YOUR DOCTOR
The effect of Laricef 1gm/1gm Injection on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Laricef 1gm/1gm Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Laricef 1gm/1gm Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Laricef 1gm/1gm Injection :
Omitting a scheduled dose of Laricef 1gm/1gm Injection warrants immediate physician consultation.
Facts to Know About Laricef 1gm/1gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
